Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bentires-Alj

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Oncogene|September 30, 2014
Mechanism-based cancer therapy: resistance to therapy, therapy for resistanceP Ramos, M Bentires-Alj
Journal of Mammary Gland Biology and Neoplasia|July 17, 2025
Reactivation of Multipotency in the Mammary Gland - a Ripple in the Pond and a Turn of the TideC Hager, C Jehanno, M Bentires-Alj
Cancer Research|February 24, 1999
Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugsM Bentires-Alj, A C Hellin, M Ameyar, et al.
Toxicology|November 25, 2000
NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatmentV Bours, G Bonizzi, M Bentires-Alj, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosisA C Hellin, M Bentires-Alj, M Verlaet, et al.
Leukemia|July 2, 2003
NF- kappa B2/p100 induces Bcl-2 expressionP Viatour, M Bentires-Alj, A Chariot, et al.
Oncogene|January 16, 2013
Tyrosine phosphatase PTPα contributes to HER2-evoked breast tumor initiation and maintenanceD S Meyer, N Aceto, N Sausgruber, et al.
Biochemical Pharmacology|September 29, 2000
Nuclear factor-kappa B, cancer, and apoptosisV Bours, M Bentires-Alj, A C Hellin, et al.
Oncogene|June 23, 2001
Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell linesM Bentires-Alj, E Dejardin, P Viatour, et al.
Cancer Gene Therapy|March 4, 2000
Cytosine deaminase suicide gene therapy for peritoneal carcinomatosisM Bentires-Alj, A C Hellin, C Lechanteur, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Oncogene|September 30, 2014
Mechanism-based cancer therapy: resistance to therapy, therapy for resistanceP Ramos, M Bentires-Alj
Journal of Mammary Gland Biology and Neoplasia|July 17, 2025
Reactivation of Multipotency in the Mammary Gland - a Ripple in the Pond and a Turn of the TideC Hager, C Jehanno, M Bentires-Alj
Cancer Research|February 24, 1999
Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugsM Bentires-Alj, A C Hellin, M Ameyar, et al.
Toxicology|November 25, 2000
NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatmentV Bours, G Bonizzi, M Bentires-Alj, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosisA C Hellin, M Bentires-Alj, M Verlaet, et al.
Leukemia|July 2, 2003
NF- kappa B2/p100 induces Bcl-2 expressionP Viatour, M Bentires-Alj, A Chariot, et al.
Oncogene|January 16, 2013
Tyrosine phosphatase PTPα contributes to HER2-evoked breast tumor initiation and maintenanceD S Meyer, N Aceto, N Sausgruber, et al.
Biochemical Pharmacology|September 29, 2000
Nuclear factor-kappa B, cancer, and apoptosisV Bours, M Bentires-Alj, A C Hellin, et al.
Oncogene|June 23, 2001
Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell linesM Bentires-Alj, E Dejardin, P Viatour, et al.
Cancer Gene Therapy|March 4, 2000
Cytosine deaminase suicide gene therapy for peritoneal carcinomatosisM Bentires-Alj, A C Hellin, C Lechanteur, et al.
Pageof 2